Fibrodysplasia ossificans progressiva – Life with Disease

Go back

Fibrodysplasia ossificans progressiva is an extremely rare genetic condition in which muscles, tendons, and ligaments gradually transform into bone, creating a second skeleton that progressively restricts movement throughout a person’s life.

Prognosis and Life Expectancy

Understanding the outlook for fibrodysplasia ossificans progressiva requires sensitivity and honesty. This condition profoundly affects life expectancy and quality of life in ways that are difficult for those unfamiliar with the disease to fully comprehend. The median survival age for people living with this condition is approximately 40 years, though with proper management and care, some individuals may live longer[4][2].

The primary cause of death in people with fibrodysplasia ossificans progressiva is thoracic insufficiency syndrome, a serious complication that develops when extra bone forms around the rib cage[4]. This abnormal bone growth prevents the lungs from expanding properly during breathing, making it increasingly difficult for the body to get enough oxygen. Over time, this can lead to respiratory failure and related complications that become life-threatening.

The progression of the disease varies considerably from person to person, making it challenging to predict exactly how quickly mobility will be lost in any individual case[5]. Some people experience rapid bone formation with frequent episodes of new bone growth, while others may have longer periods of relative stability. This unpredictability adds to the emotional burden of living with the condition, as neither patients nor their families can know with certainty what the coming months or years will bring.

⚠️ Important
The prognosis information provided here represents general patterns observed in people with fibrodysplasia ossificans progressiva. Individual outcomes can vary significantly. Many factors influence how the disease progresses, including the specific genetic mutation involved, the frequency and severity of flare-ups, and the quality of medical care received. Advances in understanding and treatment may also improve outcomes for people diagnosed today compared to those diagnosed in previous decades.

By the time most individuals with this condition reach their 30s and 40s, the accumulation of extra bone throughout the body has typically resulted in severe disability[4]. Joints that were once mobile become permanently locked in place as bone bridges form between the skeleton and the newly formed heterotopic bone. The wrists, ankles, elbows, knees, hips, and jaw gradually become involved, usually by around 40 years of age[4].

How the Disease Progresses Without Treatment

The natural course of fibrodysplasia ossificans progressiva follows a characteristic pattern that begins in early childhood and continues throughout life. The disease typically becomes noticeable during the first decade of life, though children are usually born with a telltale sign: malformed big toes[1][5]. These toe abnormalities, sometimes described as “baby bunions,” are often the first clue that something is different, though their significance may not be immediately recognized.

The progression of heterotopic ossification—the formation of bone in places where bone should not exist—follows a predictable geographical pattern through the body[4]. It moves from the upper body to the lower body, from areas closer to the center of the body outward to the extremities, and from the back of the body toward the front. This means the neck, spine, and shoulders are typically affected first, followed by the elbows, then the hips and knees, and eventually the smaller joints of the wrists and ankles.

The disease progresses through episodes called flare-ups, during which painful soft tissue swellings appear, often over the neck, back, and shoulders[5][7]. These swellings may be accompanied by low-grade fever and can last from days to months. During a flare-up, the affected area becomes inflamed, and the muscle tissue begins a transformation process. What starts as soft, swollen tissue gradually hardens and mineralizes, eventually becoming true bone that is indistinguishable from normal skeletal bone under a microscope—except that it exists in completely wrong locations[3].

Without any intervention, the continuous cycle of flare-ups and bone formation leads to progressive immobilization. Each episode adds more bone to the body’s growing second skeleton, fusing joints and restricting movement. The jaw may become locked, making it difficult to open the mouth fully. The spine may become rigid, preventing bending or twisting. The shoulders and hips may freeze in fixed positions, eliminating the ability to reach overhead or walk normally.

This relentless progression makes fibrodysplasia ossificans progressiva unique in medicine—it is the only known condition in which one type of tissue (muscle and connective tissue) transforms into another type of tissue (bone) from a different organ system[3]. The body essentially repairs injuries and responds to inflammation by creating bone instead of normal scar tissue, turning the body’s natural healing mechanisms into a source of disability.

Possible Complications

Living with fibrodysplasia ossificans progressiva means facing a range of complications that extend beyond the primary problem of unwanted bone formation. These complications can affect nearly every aspect of physical health and require careful attention to prevent or manage effectively.

Respiratory complications represent the most serious threat to life for people with this condition. As extra bone forms around the rib cage, the chest wall becomes increasingly rigid and unable to expand during breathing[1][2]. This restriction develops gradually, but over time it can severely limit lung function. People may find themselves short of breath with minimal exertion, unable to take deep breaths, and vulnerable to respiratory infections that can quickly become dangerous. The inability of the lungs to expand properly creates a situation where the body cannot get adequate oxygen, particularly during illness or physical stress.

Nutritional complications develop when bone formation affects the jaw and limits the ability to open the mouth fully[1][2]. This makes eating difficult and can severely restrict the types of food a person can consume. Over time, this leads to malnutrition—a state where the body is not receiving adequate nutrients to maintain health. Weight loss, muscle wasting, and deficiencies in essential vitamins and minerals can all result from the inability to eat normally. The psychological impact of losing the ability to enjoy food and meals with others adds another layer of difficulty to this complication.

Speaking clearly becomes increasingly challenging as the jaw becomes restricted. Communication, which most people take for granted, may require extra effort and patience. This can lead to frustration and social isolation if others struggle to understand what the person is trying to say.

Falls and injuries pose particular dangers for people with fibrodysplasia ossificans progressiva. When the upper limbs become locked in fixed positions, a person loses the natural protective reflexes that normally cushion a fall[13]. Without the ability to extend the arms to break a fall, the head and neck absorb the full impact. This makes head injuries, including potentially life-threatening epidural hematomas (bleeding between the skull and brain), more common. Some children with significant upper limb involvement may benefit from wearing protective headgear to reduce the risk of serious head injury from falls.

There is also circumstantial evidence suggesting that the disease may cause degradation of joints separate from the formation of new bone[3]. This means that in addition to losing mobility from bone fusion, people may also experience the pain and dysfunction of deteriorating joint surfaces.

⚠️ Important
Any trauma to the body—including seemingly minor injuries, medical procedures, or even viral illnesses like influenza—can trigger a flare-up that leads to new bone formation. This makes injury prevention critically important for people with fibrodysplasia ossificans progressiva. Surgical procedures, biopsies, and intramuscular injections should be avoided except in life-threatening emergencies because they almost inevitably trigger rapid bone formation in the affected area.

Impact on Daily Life

The impact of fibrodysplasia ossificans progressiva on daily life is profound and touches every dimension of human experience. Physical limitations are only part of the story; the disease affects emotional well-being, relationships, education, career possibilities, and the simple activities that most people perform without thinking.

Basic self-care activities that healthy individuals complete in minutes can become time-consuming challenges requiring assistance. Getting dressed, bathing, using the toilet, brushing teeth, and combing hair all depend on the ability to move joints freely—abilities that progressively disappear as the disease advances[11][12]. A person with locked shoulders cannot reach overhead to put on a shirt. Someone with fused elbows cannot bring a toothbrush to their mouth or a fork to their lips without adaptation. These losses of independence can be emotionally devastating and require family members or caregivers to provide intimate personal assistance.

Eating evolves from an enjoyable social activity into a careful, sometimes exhausting process. When the jaw has limited mobility, every bite must be small and carefully managed. Foods must be soft or liquid to fit through the restricted opening of the mouth. The simple pleasure of biting into an apple or enjoying a meal with friends at a restaurant becomes impossible. The social isolation that results from eating difficulties extends beyond nutrition to affect the fundamental ways humans connect with one another.

Mobility throughout the environment becomes increasingly restricted. As joints lock, walking may require assistive devices or become impossible altogether, necessitating the use of a wheelchair. But even wheelchairs present challenges—operating a standard wheelchair requires shoulder and arm mobility that many people with this condition do not have. Environmental modifications to homes, schools, and workplaces become essential. Doorways may need widening, bathrooms require complete renovation, and living spaces must be reorganized to accommodate limited mobility and assistive equipment.

The emotional and psychological impact of living with progressive disability cannot be overstated. Each flare-up brings not only physical pain but also the knowledge that more function will be lost. The uncertainty about when the next episode will occur and which body part will be affected creates ongoing anxiety. Children with the condition must cope with being different from their peers, unable to participate in the physical activities and sports that are central to childhood social life. Adults face the progressive loss of independence and the reversal of typical life trajectories, becoming increasingly dependent on others for care rather than becoming more autonomous.

Education and career opportunities face significant barriers. Children may have difficulty sitting at desks, writing by hand, or participating in physical education classes. As they grow older, career choices become limited to fields that can accommodate severe physical restrictions. Even jobs that seem possible may become unattainable as the disease progresses, forcing people to leave positions they worked hard to obtain and find meaningful.

Hobbies and recreational activities, which provide joy and purpose, become progressively more limited. Someone who loved playing an instrument, painting, gardening, or playing sports must continually adapt or ultimately give up activities that brought pleasure and identity. The grief associated with these losses is real and ongoing, requiring emotional resilience and support.

Yet many people with fibrodysplasia ossificans progressiva find ways to adapt and maintain quality of life despite these challenges. Singing is often encouraged as an activity that supports respiratory health and provides creative expression[13]. Water exercises can be beneficial because the buoyancy of water makes movement easier while minimizing the risk of injury. Assistive technology, including computer interfaces that can be operated with minimal movement, opens possibilities for communication, education, work, and entertainment.

The constant need to avoid injury shapes every decision and activity. Contact sports are absolutely prohibited. Even activities that seem safe carry risks—a trip on an uneven sidewalk, a bump from someone in a crowded space, or a dental procedure can all trigger devastating flare-ups[13]. This means living with heightened vigilance and caution that most people never have to maintain.

Support for Families: Understanding Clinical Trials

For families facing fibrodysplasia ossificans progressiva, understanding clinical trials represents an important aspect of navigating this rare disease. Clinical trials are research studies that test new approaches to preventing, detecting, or treating diseases. For extremely rare conditions like fibrodysplasia ossificans progressiva, where few treatment options exist, clinical trials may offer access to promising new therapies that are not yet available to the general public.

Families should understand that participating in a clinical trial is always voluntary and involves careful consideration of potential benefits and risks. Not every clinical trial will be appropriate for every patient, and the decision to participate should be made in consultation with the person’s medical team and with a full understanding of what participation involves.

Clinical trials for fibrodysplasia ossificans progressiva may test different types of interventions. Some trials examine medications that aim to prevent flare-ups or reduce bone formation. Others might study drugs that target the underlying genetic cause of the condition. Still others may evaluate approaches to managing symptoms or improving quality of life. Each trial has specific eligibility criteria that determine who can participate, based on factors such as age, disease stage, previous treatments, and overall health.

Family members play crucial roles in supporting someone considering or participating in a clinical trial. One of the most valuable things relatives can do is help research available trials. Several online resources list ongoing clinical trials, including national registries maintained by government health agencies. Families can search these databases using the condition name to find studies that might be appropriate. Advocacy organizations focused on fibrodysplasia ossificans progressiva, such as the International FOP Association (IFOPA), often maintain information about current trials and can help connect families with researchers[13].

Once a potentially suitable trial is identified, family members can assist with the practical aspects of evaluation and participation. This might include helping to gather medical records, coordinating communication with the research team, arranging transportation to the study site, and keeping track of appointment schedules and medication protocols. Many clinical trials require frequent visits to specialized medical centers, which may be far from home. Families may need to help arrange travel, accommodation, and time away from work or school.

Emotional support is equally important. Participating in a clinical trial involves uncertainty—there is no guarantee that the experimental treatment will be effective, and there may be unexpected side effects. Family members can provide encouragement while also helping to maintain realistic expectations. They can be present during appointments to ask questions, take notes, and ensure that the participant fully understands the information being provided by the research team.

Families should also understand the difference between clinical trials and standard medical care. In a clinical trial, some participants may receive the experimental treatment being tested, while others may receive a placebo (an inactive substance) or the current standard treatment. This randomization is necessary for scientific purposes but means that not everyone in a trial will receive the new intervention. However, all participants receive careful monitoring and medical attention throughout the study period.

Financial considerations surrounding clinical trial participation deserve discussion within families. Many trials cover the costs of the experimental treatment and research-related procedures, but they may not cover all medical expenses. Transportation, lodging, and lost wages can create financial strain. Some trials offer stipends or reimbursement for these costs, but families should clarify these details before enrolling.

It is also important for families to know that participation can be discontinued at any time without penalty and without affecting access to regular medical care. If unexpected problems arise, if the burden becomes too great, or if the participant simply changes their mind, withdrawal from a trial is always permitted.

By working together to find, evaluate, and navigate clinical trials, families can help ensure that their loved one with fibrodysplasia ossificans progressiva has access to the latest research advances while making informed decisions that align with their values and circumstances.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Palovarotene (trade name Sohonos) – An approved treatment that shows promise in managing fibrodysplasia ossificans progressiva by targeting the underlying disease mechanisms

Ongoing Clinical Trials on Fibrodysplasia ossificans progressiva

  • Study on the Safety of Intradermal mRNA COVID-19 Vaccine Bretovameran for Patients with Fibrodysplasia Ossificans Progressiva

    Recruiting

    3 1 1 1
    Investigated diseases:
    The Netherlands
  • Study on the Effectiveness of INCB000928 for Patients with Fibrodysplasia Ossificans Progressiva

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Portugal Spain
  • Study on the Safety and Effects of Saracatinib for Patients with Fibrodysplasia Ossificans Progressiva (FOP)

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Germany The Netherlands
  • Study on the Safety and Effectiveness of Garetosmab for Adults with Fibrodysplasia Ossificans Progressiva

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Finland France Italy The Netherlands Poland Spain

References

https://medlineplus.gov/genetics/condition/fibrodysplasia-ossificans-progressiva/

https://my.clevelandclinic.org/health/diseases/24476-fibrodysplasia-ossificans-progressiva

https://en.wikipedia.org/wiki/Fibrodysplasia_ossificans_progressiva

https://www.ncbi.nlm.nih.gov/books/NBK576373/

https://www.ucsfbenioffchildrens.org/conditions/fibrodysplasia-ossificans-progressiva

https://www.focusonfopus.com/all-about-fop

https://www.ucsfbenioffchildrens.org/conditions/fibrodysplasia-ossificans-progressiva

https://my.clevelandclinic.org/health/diseases/24476-fibrodysplasia-ossificans-progressiva

https://pmc.ncbi.nlm.nih.gov/articles/PMC10378717/

https://pmc.ncbi.nlm.nih.gov/articles/PMC9035442/

https://www.ipsen.com/rare-diseases/a-life-in-a-day-the-realities-of-living-with-fop/

https://www.ipsen.com/us/rare-diseases/a-life-in-a-day-the-realities-of-living-with-fop/

https://www.iccfop.org/fop-emergency-medical-care-information-and-executive-summary/

https://www.focusonfopus.com/fop-flare-ups

https://my.clevelandclinic.org/health/diseases/24476-fibrodysplasia-ossificans-progressiva

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://pmc.ncbi.nlm.nih.gov/articles/PMC6558629/

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Is fibrodysplasia ossificans progressiva hereditary?

Fibrodysplasia ossificans progressiva can be inherited in an autosomal dominant pattern, meaning only one copy of the altered gene is needed to cause the disorder. However, most cases result from new genetic mutations that occur spontaneously, with no family history of the condition. A person with FOP has a 50% chance of passing the condition to their children.

How rare is fibrodysplasia ossificans progressiva?

Fibrodysplasia ossificans progressiva is extremely rare, occurring in approximately 1 out of every 1 to 2 million people worldwide. Several hundred cases have been reported globally, with about 2,500 people currently known to have the condition. However, experts believe 80% or more of cases may be misdiagnosed, so the actual number could be higher.

Why do injuries trigger bone formation in people with FOP?

People with FOP have a mutation in the ACVR1 gene that causes bone morphogenetic protein receptors to be overactive. When tissues are damaged by trauma, surgery, or even viral illness, this abnormal receptor activity triggers the body to form bone instead of normal scar tissue during the healing process. This is why avoiding injuries and invasive medical procedures is critically important.

Can the extra bone in FOP be surgically removed?

No, surgical removal of the extra bone is strongly contraindicated in fibrodysplasia ossificans progressiva. Any surgery or tissue trauma triggers the body to form even more bone in the affected area as part of the healing response. This makes the problem worse rather than better. Non-emergency surgical procedures should be avoided in people with this condition.

What body parts does FOP affect first?

Fibrodysplasia ossificans progressiva follows a predictable pattern of progression, typically beginning in the neck and shoulders during early childhood. The disease then proceeds downward through the body and outward from the center, affecting the spine, then the elbows, followed by the hips and knees, and eventually reaching the smaller joints of the wrists and ankles by around age 40.

🎯 Key takeaways

  • Fibrodysplasia ossificans progressiva causes muscles and connective tissue to transform into bone, creating a second skeleton that progressively restricts movement throughout life.
  • The condition is extraordinarily rare, affecting only 1 in 1-2 million people worldwide, and is the only disease where tissue from one organ system transforms into another.
  • Malformed big toes present at birth are a telltale sign that helps doctors distinguish FOP from other conditions before other symptoms appear.
  • Median survival is around 40 years, with death typically resulting from thoracic insufficiency syndrome when bone formation around the rib cage prevents proper lung expansion.
  • Any trauma—including falls, surgery, biopsies, or even viral illnesses—can trigger flare-ups that lead to rapid new bone formation in the injured area.
  • The disease follows a predictable pattern, starting in the neck and shoulders during childhood and progressing downward and outward through the body over decades.
  • Surgery to remove extra bone makes the condition worse because the body responds by forming even more bone during healing, making surgical intervention contraindicated.
  • Palovarotene (Sohonos) is an approved treatment that offers promise for managing the condition, and clinical trials continue to explore new therapeutic approaches.